Effects of Sulpiride on Persistent Neuroleptic-induced Dyskinesia in Monkeys
- 1 January 1984
- journal article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 69 (S311) , 103-108
- https://doi.org/10.1111/j.1600-0447.1984.tb06862.x
Abstract
Five Cebus apella monkeys with persistent neuroleptic-induced dyskinesia were given a single dose of sulpiride (20 mg/kg i.m.). The dyskinesia was reduced in all five although four developed attacks of acute dystonia which had to be reversed by anticholinergic medication in three animals. In one monkey the administration of classic neuroleptics had earlier been shown to induce a typical sequence of events. First there was a similar reduction of dyskinesia as seen in the other monkeys, 1-2 days later there was noticed a rebound deterioration lasting for several days. Metoclopramide 0.5 mg/kg, caused such a rebound effect (for 2 days), whereas sulpiride did not.Keywords
This publication has 7 references indexed in Scilit:
- Sulpiride in tardive dyskinesiaPsychopharmacology, 1979
- The substituted benzamides - a novel class of dopamine antagonistsLife Sciences, 1979
- A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesiaPsychopharmacology, 1979
- Multiple receptors for dopamineNature, 1979
- EXTRAPYRAMIDAL SIDE-EFFECTS OF METOCLOPRAMIDEThe Lancet, 1978
- Tardive dyskinesia associated with metoclopramide.BMJ, 1978
- Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesiaPsychopharmacology, 1974